This deleterious role of melatonin in MS was also proposed by Kuklina et al.49 and Constantinescu et al.2 Moreover, in cultured human monocytes, melatonin showed a high immunoenhancing effect by activating these monocytes and increasing IL-1α and IL-1β45. The gene discussed is IL1A; the disease is myeloid sarcoma.